Following a slump in August, which posted the lowest med-tech deal values of 2024, September bounced back with the highest monthly total of the year, reaching $356.79 million.

Med-tech fundraising saw strong growth in 2024, with companies raising $21.24 billion in the first three quarters, a 48% increase over the $14.36 billion raised during the same period in 2023. However, September’s total dropped to $982.44 million, down from $3.67 billion in August.

The med-tech sector maintained its momentum in the second quarter, with total financings climbing 16.5% to $7.47 billion, compared to $6.41 billion in Q1.

Med-tech deal values dipped to $1.73 million in August, the lowest monthly total seen in 2024 and a steep drop from July’s $200.88 million.

Med-tech fundraising continued to increase through 2024, with companies securing $20.24 billion from January to August, a 47.58% jump from the $13.71 billion raised in the same period last year.